The combination of apoA-I and CIGB-258 synergistically increased the in vivo anti-inflammatory activity against CML-induced toxicity in zebrafish adults and embryos. The gene discussed is APOA1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.